Probiotics may speed recovery from eye disease, new study hopes
NCT ID NCT06527326
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether gut bacteria are linked to central serous chorioretinopathy (CSC), an eye condition that causes fluid buildup and vision problems. Researchers will compare gut bacteria in 400 people with and without CSC. They will also give some participants a Bifidobacterium supplement or a placebo for at least a month to see if it helps them recover faster and reduces the chance of the condition coming back.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Bifidobacterium supplement
- What this could lead to
- If it works, this could point toward a simple, safe supplement to help people with central serous chorioretinopathy recover faster and have fewer relapses.
- What could go wrong
- This is an early, exploratory study with only 400 participants. The supplement may not improve vision or relapse rates, and results may not apply to everyone with the condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CENTRAL SEROUS CHORIORETINOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
2 nd Affiliated Hospital, School of Medicine, Zhejiang University, China
RECRUITINGHanzhou, Zhejiang, 310000, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.